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Decades of research into cell biology,
molecular biology, biochemistry, structural
biology, and biophysics have produced a
remarkable compendium of knowledge on
the function and molecular properties of
individual proteins. This knowledge is well
recorded and manually curated into major
protein databases like UniProt [1,2]. How-
ever, proteins rarely act alone. Many times
they team up into ‘‘molecular machines’’
and have intricate physicochemical dynamic
connections to undertake biological func-
tions at both cellular and systems levels. A
critical step towards unraveling the complex
molecular relationships in living systems is
the mapping of protein-to-protein physical
‘‘interactions’’. Thecompletemap ofprotein
interactions that can occur in a living
organism is called the interactome [3].
Interactome mapping has become one of
the main scopes of current biological
research, similar to the way ‘‘genome’’
projects were a driving force of molecular
biology 20 years ago.
Efficient large-scale technologies that
measure proteome-wide physical connec-
tions between protein pairs are essential for
accomplishing a comprehensive knowledge
of the protein interactomes. In recent years,
given an explosive development of high-
throughput experimental technologies, the
number of reported protein–protein inter-
actions (PPIs) has increased substantially.
Large collections of PPIs produce ‘‘omic’’
scale views of protein partners and protein
memberships in complexes and assemblies
[4]. Over the same period as the develop-
ment of large-scale technologies, efficient
collection of a lot of small-scale experimen-
tal data published in relevant scientific
journals is also taking place. This data
compilation work is just as essential to
achieving comprehensive knowledge of the
interactome. Important efforts have been
made to build public repositories that
integrate information from large- and
small-scale PPI experiments reported in
the scientific literature. A compendium of
PPIdatabasescanbe foundinhttp://www.
pathguide.org/.
To achieve appropriate understanding
of PPIs and to design better ways for
analyzing and interpreting them, this
educational review presents several essen-
tial concepts and definitions intended
to facilitate the use of PPI information
both by computational and experimental
biologists.
The report is divided into five sections
and a summary: (a) PPI definition;a
definition of a protein-to-protein interac-
tion compared to other biomolecular
relationships or associations. (b) PPI deter-
mination by two alternative approaches: binary
and co-complex; a description of the PPIs
determined by the two main types of
experimental technologies. (c) The main
databases and repositories that include PPIs;a
description and comparison of the main
databases and repositories that include
PPIs, indicating the type of data that they
collect with a special distinction between
experimental and predicted data. (d)
Analysis of coverage and ways to improve PPI
reliability; a comparative study of the
current coverage on PPIs and presentation
of some strategies to improve the reliability
of PPI data. (e) Networks derived from PPIs
compared to canonical pathways; a practical
example that compares the characteristics
and information provided by a canonical
pathway and the PPI network built for the
same proteins. Last, a short summary and
guidance for learning more is provided.
PPI Definition
The first step needed is to define
precisely what protein–protein interactions
are. Commonly they are understood as
physical contacts with molecular docking
between proteins that occur in a cell or in
a living organism in vivo. As discussed
previously [5,6], the issue of whether two
proteins share a ‘‘functional contact’’ is
quite distinct from the question of whether
the same two proteins interact directly
with each other. Any protein in the
ribosome or in the basal transcriptional
apparatus shares a functional contact with
the other proteins in the complex, but
certainly not all the proteins in the
particular complex interact. Indubitably,
the existence of many other types of
functional links between biomolecular
entities (genes, proteins, metabolites, etc.)
in living organisms should not be confused
with protein physical interactions. Investi-
gating these functional links requires
different experimental techniques de-
signed to find such specific types of
relationships, for example, double mutant
synthetic lethality to find genetic interac-
tions [7] or transcriptome expression
profiling to find gene co-expression [8].
Identification of other types of protein
interactions (protein–DNA, protein–RNA,
protein–cofactor, or protein–ligand) is also
important for a comprehensive study of
the interactome, but again these types of
data should not be mixed or confused with
PPI data.
The physical contact considered in PPIs
should be specific, not just all proteins that
bump into each other by chance. It also
should exclude interactions that a protein
experiences when it is being made, folded,
quality checked, or degraded. For exam-
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ribosome, many touch chaperones, and
most make contact with the degradation
machinery. In many experimental assays,
such generic interactions are rightfully
filtered out. Therefore, the definition of
PPI has to consider (1st) the interaction
interface should be intentional and not
accidental, i.e., the result of specific
selected biomolecular events/forces; and
(2nd) the interaction interface should be
non-generic, i.e., evolved for a specific
purpose distinct from totally generic func-
tions such as protein production, degra-
dation, and others.
That PPIs imply physical contact be-
tween proteins does not mean that such
contacts are static or permanent. The cell
machinery undergoes continuous turnover
and reassembly. Some protein assemblies
are stable because they constitute macro-
molecular protein complexes and cellular
machines, for example ATP synthase
(eight different proteins in mammals) or
cytochrome oxidase (13 proteins in mam-
mals). These proteins included in com-
plexes are called ‘‘subunits’’. Other pro-
tein assemblies are only built to carry out
transient actions, for example, the activa-
tion of gene expression by the binding of
transcription factors and activators on the
DNA promoter region of a gene.
Another essential element for defining
PPIs is the biological context. Not all
possible interactions will occur in any cell
at any time. Instead, interactions depend
on cell type, cell cycle phase and state,
developmental stage, environmental con-
ditions, protein modifications (e.g., phos-
phorylation), presence of cofactors, and
presence of other binding partners.
PPI Determination by Two
Alternative Approaches: Binary
and Co-Complex
Experimental determinations of inter-
actions between proteins are done at either
a large or small scale with two main
technologies that produce different types
of PPI data. The techniques that measure
direct physical interactions between pro-
tein pairs are ‘‘binary’’ methods, while the
techniques that measure physical interac-
tions among groups of proteins, without
pairwise determination of protein part-
ners, are ‘‘co-complex’’ methods [9]. The
most often used binary and co-complex
methodologies are, respectively, yeast two-
hybrid (Y2H) [10] and tandem affinity
purification coupled to mass spectrometry
(TAP-MS) [11]. Both are widely applied in
large-scale investigations. Co-complex
methods measure both direct and indirect
interactions between proteins. The most
common approach is based on the pre-
selection of one protein tagged with a
molecular marker (the bait protein), which
is used to catch or ‘‘fish out’’ a group of
proteins (prey proteins) followed by a
biochemical technique to ‘‘pull-down’’
and separate them from a mix. In this
way, what takes place is a co-purification
of protein groups. Another common co-
complex approach, based on protein
antibody recognition, is co-inmunopreci-
pitation (CoIP) [5]. The experimental
results obtained with co-complex methods
are different from those obtained with
binary methods (Figure 1). Data derived
from co-complex studies cannot be direct-
ly assigned a binary interpretation. An
algorithm or model is needed to translate
group-based observations into pairwise
interactions. The spoke model is most
commonly used, as it produces the mini-
mal number of false positives [12]. An
Figure 1. Binary methods and co-complex methods: two approaches to determine PPIs. The two most widely used experimental
proteomic techniques applied to measure PPIs are yeast two-hybrid (Y2H) and tandem affinity purification coupled to mass spectrometry (TAP-MS);
the former technique is a binary method (which measures physical direct interactions between protein pairs), and the latter a co-complex method
(which measures physical interactions between groups of proteins without distinguishing whether they are direct or indirect). The interactions shown
in the left panel (green links) correspond to the true interactions existing between two groups of proteins (set A with four proteins and set B with
three proteins). The interactions shown in the right panels correspond to the networks derived from the experimentally measured interactions
existing between the six proteins analyzed: the network in the top right panel (blue links) presents the interactions obtained using a binary method;
the network in the bottom right panel (red links) presents the interactions obtained using a co-complex method. The red links are calculated applying
the spoke model to the TAP-MS experimental data, but three of the interactions deduced (links with an X) do not occur.
doi:10.1371/journal.pcbi.1000807.g001
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PLoS Computational Biology | www.ploscompbiol.org 3 June 2010 | Volume 6 | Issue 6 | e1000807Figure 2. Human interactome: overlap of six databases and coverage of 3-D structural data. Analysis of human interactome PPI data
showing the coverage of six major primary databases (BIND, BioGRID, DIP, HPRD, IntAct, and MINT), according to the integration provided by the
meta-database APID. (A) Growth of the total number of human PPIs during the last 3 years. (B) Number of PPIs obtained from each primary
repository showing the % (with respect to the total number of PPIs: 80,032 in December 2009) and the number of PPIs only reported by each
PLoS Computational Biology | www.ploscompbiol.org 4 June 2010 | Volume 6 | Issue 6 | e1000807example of networks derived from Y2H
versus TAP-MS (Figure 1) illustrates the
differences that have to be well understood
by any researcher producing or analyzing
PPI data.
The Main Databases and
Repositories That Include PPIs
Several previous publications describe
databases related to protein interactions
[13–15]. These reports do not analyze and
compare the data sources or the types of
interactions that the PPI databases in-
clude. Recent debate has questioned how
many large-scale or small-scale literature-
curated PPI data sets are included in
public databases and what is the quality of
such data [16]. In this debate, public
repositories have stated that their aim is to
collect and organize experiments support-
ing PPIs into comprehensive sets of
accurately annotated data, without a
biased selection to evidence considered
more reliable or otherwise privileged [17].
Regardless, practical users have to know
which types of interaction databases are
available, what are the differences between
them, and which are the most compre-
hensive and stable repositories.
A comparison of the main databases
and repositories that include protein
interactions is shown in Table 1, indicat-
ing the sources of the data (‘‘PPI Sourc-
es’’), the types of molecular interactions
(‘‘Type of MI’’) and the total number of
proteins and interactions (where available).
Examination of the information in Table 1
defines three different approaches in the
collection and presentation of interaction
data: (i) primary databases, which include
experimentally proven protein interactions
coming from either small-scale (Ssc) or
large-scale (Lsc) published studies that
have been manually curated; (ii) meta-
databases, which include only experimen-
tally proven PPIs obtained by consistent
integration of several primary databases
(sometimes including small sets of original
PPI data); (iii) prediction databases, which
include mainly predicted PPIs derived
using different approaches, combined with
experimentally proven PPIs. Computa-
tional methods for predicting protein
interaction partners were previously re-
viewed in [18].
There is a strong need to distinguish
between ‘‘experimental’’ PPIs and ‘‘pre-
dicted’’ PPIs in order to avoid misinter-
pretation of the results provided by one or
the other approach. Both types of data can
be useful, but it is not the same to test an
interaction between protein A and B by
Y2H as it is to infer a possible interaction
between protein A and B based on their
gene co-expression profile. In the first
situation, the PPI is experimentally prov-
en, while in the second the PPI is predicted
from experimental data obtained for the
corresponding genes, which does not
prove a direct protein interaction.
Some of the primary databases are DIP
[19], IntAct [20], and MINT [21], which
are the core founders of IMEx, the
international consortium of molecular
interaction (MI) database providers. This
consortium, together with HUPO Proteo-
mics Standards Initiative (PSI) (http://
www.psidev.info/), has defined the stan-
dard MIMIx (minimal information about
a molecular interaction) [22], which is
proposed to improve data quality and
curation of MIs. Regarding meta-databas-
es, APID [23,24] and PINA [25] represent
to date the most comprehensive efforts to
integrate PPI experimental data in single
platforms.
Analysis of Coverage and Ways
to Improve PPI Reliability
There are clear discrepancies in current
estimations of the real size of the protein
interactomes, even for the well-studied
unicellular model organism Saccharomyces
cerevisiae. An empirical estimate of the
complete binary protein interactome in S.
cerevisiae [9] finds ,18,00064,500 PPIs,
which is consistent with a previous com-
putational estimate of 16,000 to 26,000
interactions [26]. Others estimate more
than 30,000 potential interactions between
the ,6,000 proteins of this yeast [4], and
some databases with only experimental
data currently list more than 50,000
binary interactions between yeast proteins.
These observations indicate that some of
the experimentally determined PPIs in-
cluded in the databases are most probably
false positives, and therefore ways are
needed to obtain more reliable PPIs by
estimating the error rates in the data.
A first obstacle to evaluate the reliability
of PPIs is the low coverage of the
databases for each specific interactome.
One way to increase coverage is to
integrate data reported by different pri-
mary databases. Each database lacks a
substantial proportion of the total reported
PPIs [15,23]. For example, the data on
human PPIs coming from six different
primary databases show a small overlap
(Figure 2) (using a total of 80,032 interac-
tions included in APID in December
2009). In fact, there are only three PPIs
that are actually contained in all six of
these resources (i.e., full overlap). The
number of PPIs exclusively reported by
each database is large (as indicated inside
the corresponding colored circle of the
Venn diagram in Figure 2). The graph in
Figure 2A shows the observed growth of
human PPIs in the past 3 years. HPRD
and MINT are the primary databases that
include the most human PPIs: 50.7% and
34.1%, respectively.
Once the coverage is the best possible
for a given interactome, strategies for
selecting reliable PPIs are needed. A
possible solution is to incorporate 3-D
structural information about the interact-
ing proteins. This is based on the principle
that direct physical PPIs occur via specific
structural interfaces, which can often be
associated to domain pairs of known 3-D
structure, i.e., to structural domain–do-
main interactions (sddis). Integration of
sddi data with PPI data may help to
reduce false positives and can be used to
validate large-scale protein interaction
data [27].
To show the coverage of 3-D structural
data on the known human protein–protein
interactome, we produced three different
subsets of this interactome at three levels
of confidence: (i) a subset of the complete
human PPI data including only the
proteins that have at least one Pfam
domain assigned: 69,079 interactions,
called ppihs_all (Figure 2C); (ii) a subset of
ppihs_all with only the interactions that
have been validated by at least two
experimental methods that demonstrate
the interaction or by the same experimen-
tal method reported in at least two
independently published articles: 16,959
interactions, called ppihsx2meth (Figure 2D);
(iii) a subset of ppihs_all with only the
database (shown inside the corresponding sector of the Venn diagram). Coverage and intersection of PPIs with 3-D structural information: (C)
Intersection between the PPIs of all human proteins that have at least one Pfam annotated (69,079 interactions, called ppihs_all) and the PPIs that
include proteins with 3-D structural information (9,879 interactions, called ppihsxsdd); (D) intersection between the PPIs with 3-D structural
information and a more stringent interactome constituted by PPIs proven at least by two experimental methods (16,959 interactions, called
ppihsx2meth); (E) intersection between the PPIs with 3-D structural information and more stringent interactome constituted by interactions between
proteins that are annotated to the same KEGG functional pathway (7,693 interactions, called ppihsxKEGG).
doi:10.1371/journal.pcbi.1000807.g002
PLoS Computational Biology | www.ploscompbiol.org 5 June 2010 | Volume 6 | Issue 6 | e1000807Figure 3. A network derived from PPIs compared to the related canonical pathway. Comparison between a known pathway (NOTCH
signaling pathway, taken from the KEGG database, ID: hsa04330) and the corresponding interactome network build using the proteins that interact
with human NOTCH proteins. The top panel (A) shows the pathway including nine proteins (green boxes) directly connected to NOTCH. In this
pathway, the central element is the NOTCH receptor and the interaction of its intracellular domain (called NICD) with protein RBPJ. The bottom panel
(B) shows the NOTCH PPI network (built with Cytoscape and APID2NET), including all interactors proven with at least two different experiments. The
number of experiments is indicated next to each link (blue line). The PPI network provides complementry information to the KEGG pathway, revealing
the particular links of each of the four NOTCH paralogous proteins (NOTCH1, 2, 3, and 4) present in the human proteome. The biomolecular elements
included in both networks are quite similar and the information that can be deduced from them is complementary. This can be seen in the
interaction between NOTCH and RBPJ that drives the central signaling of the pathway and it is present in both networks.
doi:10.1371/journal.pcbi.1000807.g003
PLoS Computational Biology | www.ploscompbiol.org 6 June 2010 | Volume 6 | Issue 6 | e1000807interactions corresponding to proteins that
work together in the same KEGG biolog-
ical pathway: 7,693 interactions, called
ppihsxKEGG (Figure 2E) (http://www.
genome.jp/kegg/pathway.html). Besides
these three groups, we built another subset
including all protein pairs supported by
structural domain–domain interactions
(called ppihsxsdd), selecting human PPIs that
had at least one structural domain pair
reported by one sddi resource. The sddi
repositories are based on the analysis of 3-D
structural interactions between protein do-
mains taken from the PDB database [27].
The ppihsxsdd subset includes 3,688 human
proteins and 9,879 interactions. The Venn
diagrams (Figure 2C–2E) indicate that the
coverage of structural data increases from
14.3% to 21.4% and 30.3%, following the
increase in ‘‘stringency’’ of the interactome
datasets. Therefore, the structural validation
can helpto increase reliability of PPIdata, as
shown by the larger percentage (21.4%) of
sddis getting included in the interactome
proven by two methods (ppihsx2meth).
Networks Derived from PPIs
Compared to Canonical
Pathways
In several PPI repositories, it is a
straightforward process to obtain all the
proteins that interact with a given query
protein and from those to build a corre-
sponding network of molecular interactions.
Several bioinformatic tools have been de-
veloped to represent and explore such PPI
networks. Probably the most useful ones are
associated with Cytoscape (http://www.
cytoscape.org/), an open-source bioinfor-
matics software platform for visualizing
molecular interaction networks and biolog-
ical pathways and for integrating these
networks with annotations and other types
of data [28,29]. There are several Cytoscape
p l u g - i n st h a tc a nb eu s e dt od o w n l o a da n d
explore PPIs: APID2NET allows direct data
import from the APID repository [24];
BiogridPlugin allows import from BioGRID
[30]; MiMIplugin retrieves molecular inter-
actions from the MiMI database [31]; and
IntActWSClient, StringWSClient, and
PathwayCommons WSC are Web service
clients accessible from Cytoscape through
the Web Service Client Manager that
provide connectivity to IntAct, STRING
[20,32], or Pathway Commons (http://
www.pathwaycommons.org/).
It is worthwhile to compare the char-
acteristics and information provided by a
PPI network with the information about
the corresponding canonical pathway in-
volving the same proteins. We present a
practical example by comparing the hu-
man NOTCH signaling pathway to the
corresponding PPI network obtained with
the interactions of the four NOTCH
human proteins (Figure 3). The first one
was directly taken from KEGG (ID:
hsa04330) (Figure 3A), which is probably
the most complete, well-integrated, and
annotated database of biological pathways
[33,34]. The second network was built
using APID2NET and Cytoscape, retriev-
ing the proteins that interact with
NOTCH1, NOTCH2, NOTCH3, or
NOTCH4 (UniProt IDs: P46531,
Q04721, Q9UM47, Q99466) in interac-
tions demonstrated by at least two differ-
ent experiments (Figure 3B).
The KEGG pathway representation does
not distinguish the relations between the
four NOTCH paralogous proteins, while
the PPI network separates the links proven
for each NOTCH paralogous protein. By
contrast,theKEGGpathwayrepresentation
distinguishes the direction and properties of
the links, while the PPI network does not
include such directional information. The
biomolecular elements (i.e., the nodes) in
both networks are generally similar, and the
information that can be deduced from them
is complementary, each single view being
enriched by the other. The c-secretase
complex is not included in the PPI network,
while the interaction of NOTCH with the
SMAD pathway isnot present inthe KEGG
network. The central role of NOTCH and
RBPJisrepresentedinbothviews(Figure3A
and 3B), showing that this intracellular
interaction drives the signaling pathway. In
conclusion, the use of PPI data combined
with related pathways allows for a useful and
detailed exploration of protein networks.
This approach may bring about better
comprehension of the complex functional
roles that the proteins play by physically
interacting in living systems.
Summary and Guidance for
Learning More
This tutorial presents an up to date
overview of PPIs, which are defined as
specific physical contacts between protein pairs that
occur by selective molecular docking in a particular
biological context. Following this definition,
we present some concepts related to the
experimental methods used to determine
PPIs, the types of biological repositories
that include PPIs, and some strategies for
analyzing the quality of protein interac-
tions. Adequate description of the main
characteristics of each PPI, including
complete biological information about
the proteins, is essential for building
reliable protein interaction networks. As
a guide for building and analyzing inter-
actome networks, the tutorial provides a
broad collection of references about
PPI data resources [19–21,23,25,30–32]
and about related bioinformatic tools
[24,28–32]. PPI networks can provide a
complementary view to the biological
pathways that enclose the corresponding
proteins. Looking forward, two main
challenges remain for the field and for
database providers: (i) a better filtering of
false positives in PPI collections and (ii) an
adequate distinction of the biological
context that specifies and determines the
existence or not of a given PPI at a given
biological situation.
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